MedPath

Efficacy and safety of hourly titrated misoprostol versus vaginal dinoprostone and misoprostol for and labor induction: randomized clinical trial.

Phase 1
Active, not recruiting
Conditions
labor induction
Therapeutic area: Body processes [G] - Physiological processes [G07]
Registration Number
EUCTR2015-003412-20-ES
Lead Sponsor
Basque Health System
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

? Women over 18
? single pregnancy
? cephalic presentation
? intact membranes
? unfavorable cervix ( less than 6 Bishop )
? CTGR not reactive decelerative
? Signed informed consent by the patient.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 372
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

? prior Cesarean section or previous uterine surgery .
? Allergy or intolerance to any of the study drugs
? stillbirth
? uterine growth restricted fetuses
? contraindication for vaginal delivery
? Anterior placenta
? Multiparity
? moderate to severe heart disease
? hypertensive disorders of pregnancy
? Suspected chorioamnionitis

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
Âİ Copyright 2025. All Rights Reserved by MedPath